foxo4 dri senolytic or senomorphic FOXO4-DRI UK | Peptide Research Full article: Targeting Cellular Senescence
Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Buy FOXO4 DRI (10mg) (Proxofim) 99% Purity USA Made Peptide The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



